Nicotinamide Riboside—The Current State of Research and Therapeutic Uses ReviewANAD StaffMay 31, 2020Review
Implications of NAD+ Metabolism in the Aging Retina and Retinal Degeneration Sensory, Aging, ReviewANAD StaffMay 11, 2020Review, Aging, Sensory
Therapeutic potential of nicotinamide adenine dinucleotide (NAD) ReviewANAD StaffApril 28, 2020Review
Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing ReviewANAD StaffJanuary 20, 2020Review
NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis ReviewANAD StaffJanuary 7, 2020Review
The iNADequacy of renal cell metabolism: modulating NAD+ biosynthetic pathways to forestall kidney diseases ReviewANAD StaffJuly 23, 2019Review
Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases ReviewANAD StaffJuly 7, 2019Review
Therapeutic potential of NAD-boosting molecules: The in vivo evidence ReviewANAD StaffMarch 6, 2018Review
NAD(+) intermediates: The biology and therapeutic potential on NMN and NR ReviewANAD StaffDecember 14, 2017Review
NAD(+) in aging: Molecular mechanisms and translational implications ReviewANAD StaffSeptember 9, 2017Review
NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus ReviewANAD StaffJune 25, 2015Review
Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition ReviewANAD StaffApril 22, 2008Review
